Session

PP 05 IBD (Posters)

VITAMIN D DEFICIENCY IS ASSOCIATED WITH POOR DISEASE OUTCOME UNDER ANTI-TNF THERAPY IN CHILDREN WITH IBD
VITAMIN D DEFICIENCY IS ASSOCIATED WITH POOR DISEASE OUTCOME UNDER ANTI-TNF THERAPY IN CHILDREN WITH IBD

ADHERENCE TO GUIDELINES AFTER ILEOCOLONIC RESECTION FOR CROHN'S DISEASE: AN AUSTRALIAN EXPERIENCE
ADHERENCE TO GUIDELINES AFTER ILEOCOLONIC RESECTION FOR CROHN'S DISEASE: AN AUSTRALIAN EXPERIENCE

DUAL THERAPY WITH CAROTEGRAST (AJM300: ORAL Α4 INTEGRIN ANTAGONIST) AND BIOLOGICS FOR REFRACTORY ULCERATIVE COLITIS
DUAL THERAPY WITH CAROTEGRAST (AJM300: ORAL Α4 INTEGRIN ANTAGONIST) AND BIOLOGICS FOR REFRACTORY ULCERATIVE COLITIS

EXPOSURE TO ANTI-TNFΑ AGENT IS ASSOCIATED WITH THE DEVELOPMENT OF AUTOIMMUNE DISEASE IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED CASE-CONTROL STUDY
EXPOSURE TO ANTI-TNFΑ AGENT IS ASSOCIATED WITH THE DEVELOPMENT OF AUTOIMMUNE DISEASE IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED CASE-CONTROL STUDY

TREATMENT DISCONTINUATION DUE TO LACK OF EFFICACY DURING MAINTENANCE TREATMENT WITH INFLIXIMAB OR VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE: A COMPARATIVE ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
TREATMENT DISCONTINUATION DUE TO LACK OF EFFICACY DURING MAINTENANCE TREATMENT WITH INFLIXIMAB OR VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE: A COMPARATIVE ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

PREVALENCE OF CMV INFECTION IN IBD PATIENTS : DEFINING PREVALENCE, CLINICAL PROFILE AND OUTCOMES IN OUR CLINICAL PRACTICE
PREVALENCE OF CMV INFECTION IN IBD PATIENTS : DEFINING PREVALENCE, CLINICAL PROFILE AND OUTCOMES IN OUR CLINICAL PRACTICE

HOW CAN WE PREDICT THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN CROHN’S DISEASE?
HOW CAN WE PREDICT THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN CROHN’S DISEASE?

CORRELATION OF CALPROTECTIN AND BOWEL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE (IBD)
CORRELATION OF CALPROTECTIN AND BOWEL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE (IBD)

ANTI-TNF MONITORING EXPERIENCE IN A 3RD LEVEL HOSPITAL IN LATIN AMERICA
ANTI-TNF MONITORING EXPERIENCE IN A 3RD LEVEL HOSPITAL IN LATIN AMERICA

DATA IN A TERTIARY HOSPITAL ON SWITCHING FROM AN INTENSIFIED AND NON INTENSIFIED REGIMEN OF INTRAVENOUS VEDOLIZUMAB TO A SUBCUTANEOUS IN ADULTS WITH INFLAMMATORY BOWEL DISEASE
DATA IN A TERTIARY HOSPITAL ON SWITCHING FROM AN INTENSIFIED AND NON INTENSIFIED REGIMEN OF INTRAVENOUS VEDOLIZUMAB TO A SUBCUTANEOUS IN ADULTS WITH INFLAMMATORY BOWEL DISEASE

POSSIBLE THERAPEUTIC EFFECT OF HELIX POMATIA MUCUS ON AN EXPERIMENTALLY INDUCED MODEL OF ULCERATIVE COLITIS
POSSIBLE THERAPEUTIC EFFECT OF HELIX POMATIA MUCUS ON AN EXPERIMENTALLY INDUCED MODEL OF ULCERATIVE COLITIS

CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SULFATE SODIUM–INDUCED COLITIS IN RATS
CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SULFATE SODIUM–INDUCED COLITIS IN RATS

PERFORMANCE OF INTESTINAL ULTRASOUND SCORES IN DETECTING ACTIVE CROHN'S DISEASE
PERFORMANCE OF INTESTINAL ULTRASOUND SCORES IN DETECTING ACTIVE CROHN'S DISEASE

UPPER GASTROINTESTINAL TRACT INVOLVEMENT IN CROHN’S DISEASE: IMPACT ON CLINICAL PROFILE AND DISEASE COURSE
UPPER GASTROINTESTINAL TRACT INVOLVEMENT IN CROHN’S DISEASE: IMPACT ON CLINICAL PROFILE AND DISEASE COURSE

SAFETY AND EFFECTIVENESS OF COMBINING BIOLOGICS AND SMALL MOLECULES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: AN UPDATED SYSTEMATIC REVIEW WITH METANALYSIS
SAFETY AND EFFECTIVENESS OF COMBINING BIOLOGICS AND SMALL MOLECULES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: AN UPDATED SYSTEMATIC REVIEW WITH METANALYSIS

THE ROLE OF CHEST X-RAYS WHEN SCREENING FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE STARTING BIOLOGIC TREATMENT
THE ROLE OF CHEST X-RAYS WHEN SCREENING FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE STARTING BIOLOGIC TREATMENT

ARE RECTAL OR RECTOSIGMOID ENDOSCOPY SUFFICIENT TO ASSESS COMPLETE ENDOSCOPIC OR HISTOLOGICAL HEALING IN ULCERATIVE COLITIS: A CROSS-SECTIONAL STUDY
ARE RECTAL OR RECTOSIGMOID ENDOSCOPY SUFFICIENT TO ASSESS COMPLETE ENDOSCOPIC OR HISTOLOGICAL HEALING IN ULCERATIVE COLITIS: A CROSS-SECTIONAL STUDY

JAK INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: RESULTS OF AN INTERNATIONAL SURVEY OF PERCEPTIONS, ATTITUDES, AND CLINICAL PRACTICE
JAK INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: RESULTS OF AN INTERNATIONAL SURVEY OF PERCEPTIONS, ATTITUDES, AND CLINICAL PRACTICE

A GLOBAL CONSENSUS ON THE DEFINITIONS, DIAGNOSIS AND MANAGEMENT OF FIBROSTENOSING SMALL BOWEL CROHN'S DISEASE
A GLOBAL CONSENSUS ON THE DEFINITIONS, DIAGNOSIS AND MANAGEMENT OF FIBROSTENOSING SMALL BOWEL CROHN'S DISEASE

LONG-TERM VEDOLIZUMAB PERSISTENCE IN ULCERATIVE COLITIS: THE EDINBURGH IBD UNIT EXPERIENCE 2014-2022
LONG-TERM VEDOLIZUMAB PERSISTENCE IN ULCERATIVE COLITIS: THE EDINBURGH IBD UNIT EXPERIENCE 2014-2022

Item 521 - 540 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
27
28 29 30 31 32 33 34 35 36 37 38 39 40 41 42